This brand name is authorized in Australia, Brazil, Germany, Estonia, Spain, France, Hong Kong, Ireland, Italy, Japan, Malta, Netherlands, Poland, Turkey, United States, South Africa

Active ingredients

The drug PARLODEL contains one active pharmaceutical ingredient (API):

1 Bromocriptine

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

Read about Bromocriptine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PARLODEL Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G02CB01 Bromocriptine G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB01
N04BC01 Bromocriptine N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1443Y, 1444B
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526512503112319, 526512504119317
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 11030323, 11030346
Country: EE Ravimiamet Identifier(s): 1464993
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 54633, 56200
Country: FR Base de données publique des médicaments Identifier(s): 63369053, 64141483, 66729097
Country: HK Department of Health Drug Office Identifier(s): 01595
Country: IE Health Products Regulatory Authority Identifier(s): 69175
Country: IT Agenzia del Farmaco Identifier(s): 023781014
Country: JP 医薬品医療機器総合機構 Identifier(s): 1169005F1200
Country: MT Medicines Authority Identifier(s): AA1279/00101
Country: NL Z-Index G-Standaard, PRK Identifier(s): 3239
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100051684, 100259462, 100288660, 100328884, 100394183, 100407804, 100426196
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8698856010032, 8698856170040, 8698856170057
Country: US FDA, National Drug Code Identifier(s): 30698-201, 30698-202
Country: ZA Health Products Regulatory Authority Identifier(s): Q/21.12/76

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.